Ammunition Life-tech, a Chinese cancer screening company, has refiled for an IPO on the Hong Kong Stock Exchange despite widening net losses and a high valuation. The company reported 2025 revenues of 15.42 million yuan but net losses increased by 26.8% to 48.98 million yuan due to rising R&D and administrative costs. Its valuation implies a price-to-sales ratio of 147 times, which is challenging in the current bearish market for cancer diagnostics. The firm also faces risks from a concentrated customer base linked to related parties. Investor confidence will be tested as the company has no clear profit timeline amid sector downturns and recent troubles for peers in the market.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) has outperformed Bitcoin (BTC) in Q3, driven by a rally sparked by a softer CPI report and strong on-chain metrics. The recent surge pushed ETH above $1,900, triggering significant liquidations in futures positions. However, ETH now fa...
Solana's number of wallets holding tokenized real-world assets (RWAs) has exceeded 300,000, surpassing Ethereum's roughly 200,000 holders. While Solana's RWA value doubled in 2026 to $3.45 billion, Ethereum still leads with $16.3 billion in tokenized...
Baidu's board has approved a plan to convert to a dual-primary listing on the Hong Kong Stock Exchange's Main Board, alongside its existing Nasdaq listing. This move aims to enhance the liquidity of Baidu's shares, broaden its investor base, and prov...
